Division of Hematology and Oncology
Initiatives include evaluation of mechanisms designed to lessen drug resistance in patients on cancer chemotherapy. In the field of breast cancer, projects are underway to evaluate the impact of treatment on sexuality and the physical changes that occur among women who participate in an exercise program following chemotherapy.
Breast Cancer Risk Reduction, Breast Cancer Treatment, Head and Neck Cancer
University of Tennessee, Memphis, 1983
Internal Medicine, University of Massachusetts in Worchester Memorial Hospital, Massachusetts, 1986
Hematology/Oncology, Duke University Medical Center, North Carolina, 1989
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Pannell TA, Panella TJ, Zaretzki RL.
The prognostic impact of determining treatment plans based on discordant metastatic tumor receptors on relapse. American Journal of Hematology / Oncology. 2016;12(9):14-20.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2019